The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Insmed announced the FDA has granted breakthrough therapy designation for brensocatib for non-cystic fibrosis bronchiectasis for reducing ...
read more
Sound Pharmaceuticals announced the FDA has allowed its pivotal Phase 3 clinical protocol for SPI-1005 in the Treatment of Patients with Meniere's ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Rakuten Medical and MD Anderson announced an agreement to advance the development of new cancer therapies based on Rakuten Medical's proprietary ...
read more
Adamas announced its sNDA for GOCOVRI as a treatment for OFF episodes in Parkinson’s disease has been accepted for review by the FDA.
read more
Relief and NeuroRx announced the Phase 2/3 clinical trial evaluating RLF-100 treatment for critical COVID-19 with respiratory failure.
read more
Novartis has received notice from the FDA the agency has extended its review of the sBLA for ofatumumab, a self-administered, targeted B-cell therapy ...
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
TVAX Biomedical announced receipt of Fast Track Designation from the FDA for the use of its VACT for treatment of glioblastoma multiforme.
read more
FSD announced the FDA has given the company permission to submit an IND for the use of FSD-201 to treat COVID-19.
read more
Shionogi announced the FDA has accepted the company’s sNDA for FETROJA and granted Priority Review designation with a Prescription Drug User Fee Act.
read more
The FDA has approved atezolizumab in combination with bevacizumab for patients with unresectable or metastatic hepatocellular carcinoma.
read more
Braeburn has requested final approval from the FDA of the NDA for BRIXADI weekly and monthly extended-release injection for the treatment of opioid ...
read more
MimiVax announced a clinical collaboration to assess the combination of SurVaxM and pembrolizumab.
read more
Relief Therapeutics and NeuroRx announced treatment of the first patients with RLF-100 at the University of Miami Miller School of Medicine, FL.
read more